title: In reply to Mireskandari and coworkers.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Blair
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Shapiro
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D006801:Humans; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized